Individuals with obesity are susceptible to iron deficiency and related hematological conditions. Adipose tissue, considered an endocrine organ, can influence iron metabolism and erythropoiesis, potentially leading to decreased iron bioavailability even with sufficient dietary intake. For example, inflammatory cytokines released from adipose tissue can interfere with iron absorption and utilization.
Understanding the link between increased body mass and iron deficiency is crucial for public health initiatives. Early detection and appropriate intervention can prevent adverse health outcomes associated with both conditions. Further research into the underlying mechanisms may lead to targeted therapies and improved management strategies.
